AU Patent

AU2014249534B2 — Use of levocetirizine and montelukast in the treatment of vasculitis

Assigned to Irr Inc · Expires 2018-08-30 · 8y expired

What this patent protects

The embodiments described herein include methods and formulations for treating vasculitis. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The me…

USPTO Abstract

The embodiments described herein include methods and formulations for treating vasculitis. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified- release elements, providing for drug delivery to the patient.

Drugs covered by this patent

Patent Metadata

Patent number
AU2014249534B2
Jurisdiction
AU
Classification
—
Expires
2018-08-30
Drug substance claim
No
Drug product claim
No
Assignee
Irr Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.